Drug Device Combination Products Market by Device Types (Drug Eluting Stents, Coronary Stents, Peripheral Vascular Stents, Infusion Pumps, Implantable Infusion Pumps, Ambulatory Infusion Pumps, Photosensitizers, orthopedic Combination Products, Antibiotic Bone Cement, Bone Graft Implants, Wound Care Combination Products, Antibiotic Wound Care Products, Inhalers, Nebulizers, Metered Dose Inhalers, Dry Powder Inhalers, Transdermal Patches, Intraocular Implants, Drug Eluting Beads) and Forecast 2017-2021

Drug Device Combination Products Market by Device Types (Drug Eluting Stents, Coronary Stents, Peripheral Vascular Stents, Infusion Pumps, Implantable Infusion Pumps, Ambulatory Infusion Pumps, Photosensitizers, orthopedic Combination Products, Antibiotic Bone Cement, Bone Graft Implants, Wound Care Combination Products, Antibiotic Wound Care Products, Inhalers, Nebulizers, Metered Dose Inhalers, Dry Powder Inhalers, Transdermal Patches, Intraocular Implants, Drug Eluting Beads) and Forecast 2017-2021

A drug device combination product is composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product. Under 21 CFR 3.2 (e), a combination product is defined as a product comprised of two or more regulated components (i.e., drug/device, biologic/device, drug/biologic, or drug/device/biologic) that are physically, chemically, or otherwise combined or mixed and produced as a single entity; and, two or more separate products packaged together in a single package or as a unit and comprised of drug and device products, device and biological products, or biological and drug products.

The global drug device combination products market segmentation is based on device types (drug eluting stents, coronary stents, peripheral vascular stents, infusion pumps, implantable infusion pumps, ambulatory infusion pumps, photosensitizers, orthopedic combination products, antibiotic bone cement, bone graft implants, wound care combination products, antibiotic wound care products, inhalers, nebulizers, metered dose inhalers, dry powder inhalers, transdermal patches, intraocular implants, drug eluting beads).

The global drug device combination products market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global drug device combination products market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Drugs
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Drug Class or Drug (Brand) Type
    • Drug or Disorder Test
    • Indication Type
    • Drug Treatment
    • Mechanism of Action
    • Therapeutic Area or Nature of Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • IND, NDA filed, FDA, EMEA Approvals
  8. Pipeline Analysis(Phase 1, 2 and 3 Drugs)
    • Phase 3 Drugs Forecast Estimation (Approval to 2025)
    • Phase 1 and 2 Drugs – Qualitative Analysis
  9. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  10. Recommendations
  11. References

Drug Device Combination Products Market

1. Device Type
1.1 Drug Eluting Stents
1.1.1 Coronary stents
1.1.2 Peripheral Vascular Stents
1.2 Infusion Pumps
1.2.1 Implantable Infusion Pumps
1.2.2 Ambulatory Infusion Pump
1.3 Photosensitizers
1.4 Orthopedic Combination Products
1.4.1 Antibiotic Bone Cement
1.4.2 Bone Graft Implants
1.5 Wound Care Combination Products
1.5.1 Antibiotic Wound Care Products
1.6 Inhalers
1.6.1 Nebulizers
1.6.2 Metered Dose Inhalers
1.6.3 Dry Powder Inhalers
1.7 Transdermal Patches
1.8 Others (Intraocular Implants, Drug Eluting Beads, etc.)

2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World

3. Company Profiles
3.1 Abbott Laboratories
3.2 Allergan, Inc.
3.3 Alcon, Inc.
3.4 Arrow International, Inc.
3.5 Bausch & Lomb, Inc.
3.6 Boston Scientific Corporation
3.7 CareFusion Corporation
3.8 Covidien PLC
3.9 C.R. Brad, Inc.
3.10 Ethicon, Inc.
3.11 Medline Industries, Inc.
3.13 Medtronic, Inc.
3.14 Mylan, Inc.
3.15 Pinnacle Biologics, Inc.
3.16 Stryker Corporation
3.17 Terumo Corporation
3.18 W.L. Gore & Associates, Inc.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*